These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 31129209)
1. The immunotoxin activity of exotoxin A is sensitive to domain modifications. Amiri Tehranizadeh Z; Sankian M; Fazly Bazzaz BS; Chamani J; Mehri S; Baratian A; Saberi MR Int J Biol Macromol; 2019 Aug; 134():1120-1131. PubMed ID: 31129209 [TBL] [Abstract][Full Text] [Related]
2. Expression and purification of recombinant immunotoxin--a fusion protein stabilizes a single-chain Fv (scFv) in denaturing condition. Kim SH Protein Expr Purif; 2003 Jan; 27(1):85-9. PubMed ID: 12509988 [TBL] [Abstract][Full Text] [Related]
3. Designing the furin-cleavable linker in recombinant immunotoxins based on Pseudomonas exotoxin A. Weldon JE; Skarzynski M; Therres JA; Ostovitz JR; Zhou H; Kreitman RJ; Pastan I Bioconjug Chem; 2015 Jun; 26(6):1120-8. PubMed ID: 25997032 [TBL] [Abstract][Full Text] [Related]
4. Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A. Kaplan G; Lee F; Onda M; Kolyvas E; Bhardwaj G; Baker D; Pastan I Toxins (Basel); 2016 Jul; 8(8):. PubMed ID: 27463727 [TBL] [Abstract][Full Text] [Related]
5. Modular Conjugation of a Potent Anti-HER2 Immunotoxin Using Coassociating Peptides. Stoessel A; Groysbeck N; Guyot L; Barret L; Nominé Y; Nguekeu-Zebaze L; Bender A; Voilquin L; Lutz T; Pallaoro N; Blocat M; Deville C; Masson M; Zuber G; Chatton B; Donzeau M Bioconjug Chem; 2020 Oct; 31(10):2421-2430. PubMed ID: 32996763 [TBL] [Abstract][Full Text] [Related]
6. A chemical conjugate between HER2-targeting antibody fragment and Pseudomonas exotoxin A fragment demonstrates cytotoxic effects on HER2-expressing breast cancer cells. Lee S; Park S; Nguyen MT; Lee E; Kim J; Baek S; Kim CJ; Jang YJ; Choe H BMB Rep; 2019 Aug; 52(8):496-501. PubMed ID: 30670149 [TBL] [Abstract][Full Text] [Related]
7. Increased affinity and stability of an anti-HIV-1 envelope immunotoxin by structure-based mutagenesis. McHugh L; Hu S; Lee BK; Santora K; Kennedy PE; Berger EA; Pastan I; Hamer DH J Biol Chem; 2002 Sep; 277(37):34383-90. PubMed ID: 12119300 [TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy. Chen H; Gao J; Lu Y; Kou G; Zhang H; Fan L; Sun Z; Guo Y; Zhong Y J Control Release; 2008 Jun; 128(3):209-16. PubMed ID: 18450313 [TBL] [Abstract][Full Text] [Related]
9. Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems. Della Cristina P; Castagna M; Lombardi A; Barison E; Tagliabue G; Ceriotti A; Koutris I; Di Leandro L; Giansanti F; Vago R; Ippoliti R; Flavell SU; Flavell DJ; Colombatti M; Fabbrini MS Microb Cell Fact; 2015 Feb; 14():19. PubMed ID: 25889802 [TBL] [Abstract][Full Text] [Related]
10. B3(Fab)-PE38M: a recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3. Choe M; Webber KO; Pastan I Cancer Res; 1994 Jul; 54(13):3460-7. PubMed ID: 8012967 [TBL] [Abstract][Full Text] [Related]
11. Generation of Single-Domain Antibody-Based Recombinant Immunotoxins. Fleming BD; Ho M Methods Mol Biol; 2022; 2446():489-512. PubMed ID: 35157290 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of fusion protein truncated Pseudomonas Exotoxin A (PE38KDEL) in Escherichia coli. Song S; Xue J; Fan K; Kou G; Zhou Q; Wang H; Guo Y Protein Expr Purif; 2005 Nov; 44(1):52-7. PubMed ID: 15922623 [TBL] [Abstract][Full Text] [Related]
13. Design of a modular immunotoxin connected by polyionic adapter peptides. Kleinschmidt M; Rudolph R; Lilie H J Mol Biol; 2003 Mar; 327(2):445-52. PubMed ID: 12628249 [TBL] [Abstract][Full Text] [Related]
14. A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer. Weldon JE; Pastan I FEBS J; 2011 Dec; 278(23):4683-700. PubMed ID: 21585657 [TBL] [Abstract][Full Text] [Related]
15. Novel Anti-Mesothelin Nanobodies and Recombinant Immunotoxins with Nguyen MQ; Kim DH; Shim HJ; Ta HKK; Vu TL; Nguyen TKO; Lim JC; Choe H Mol Cells; 2023 Dec; 46(12):764-777. PubMed ID: 38052492 [TBL] [Abstract][Full Text] [Related]
16. Recombinant immunotoxin containing a disulfide-stabilized Fv directed at erbB2 that does not require proteolytic activation. Kuan CT; Pastan I Biochemistry; 1996 Mar; 35(9):2872-7. PubMed ID: 8608123 [TBL] [Abstract][Full Text] [Related]
17. Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections. Brinkmann U; Buchner J; Pastan I Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3075-9. PubMed ID: 1557415 [TBL] [Abstract][Full Text] [Related]
18. Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention. Fleming BD; Urban DJ; Hall MD; Longerich T; Greten TF; Pastan I; Ho M Hepatology; 2020 May; 71(5):1696-1711. PubMed ID: 31520528 [TBL] [Abstract][Full Text] [Related]
19. Immunotoxin-mediated targeting of claudin-4 inhibits the proliferation of cancer cells. Hashimi SM; Yu S; Alqurashi N; Ipe DS; Wei MQ Int J Oncol; 2013 Jun; 42(6):1911-8. PubMed ID: 23563899 [TBL] [Abstract][Full Text] [Related]
20. Monovalent immunotoxin containing truncated form of Pseudomonas exotoxin as potent antitumor agent. Debinski W; Pastan I Cancer Res; 1992 Oct; 52(19):5379-85. PubMed ID: 1394141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]